本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

22.03
-1.5100-6.41%
盤後22.170.1400+0.64%19:55 EDT
成交量:154.86萬
成交額:3,506.36萬
市值:13.10億
市盈率:-9.17
高:23.96
開:23.63
低:21.86
收:23.54
52周最高:40.65
52周最低:11.82
股本:5,948.52萬
流通股本:3,521.10萬
量比:0.64
換手率:4.40%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
淨資產收益率:-45.31%
總資產收益率:-28.46%
市淨率:3.71
市盈率(LYR):-10.95

資料載入中...

2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/19

SEC問詢函

Form CORRESP - Correspondence
2024/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]